Not recruitingISRCTN14037337
Baduanjin combined with computerized cognitive remediation therapy for the treatment of schizophrenia : a 8-week randomized controlled trial
Research studyAges 0–80China
Understand this study
Who could participate?
This study is for people with schizophrenia. Listed age limits: 0 years to 80 years. Other eligibility criteria apply.
- Listed locations
- China
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- The Second People's Hospital of Chuzhou (also the Municipal Infectious Disease Hospital and the Municipal Psychiatric Hospital of Chuzhou)
- Sponsor type
- Hospital / academic medical center
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- China
- Age range
- From 0 Years to 80 Years
- Official registry ID
- ISRCTN14037337
- Official title
Show the full official title
Baduanjin combined with computerized cognitive remediation therapy for the treatment of schizophrenia : a 8-week randomized controlled trial
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
China
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The Second People's Hospital of Chuzhou (also the Municipal Infectious Disease Hospital and the Municipal Psychiatric Hospital of Chuzhou), a hospital or academic medical center.
Who can participate?
This study is for people with schizophrenia. Listed age limits: 0 years to 80 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
